Bio-Rad Laboratories, Inc. (US) and Thermo Fisher Scientific, Inc. (US) are Leading Players in the IVD Quality Control Market
The global IVD quality control market is projected to reach USD 1.6 billion by 2027 from USD 1.3 billion in 2022, at a CAGR of 5.4% during the forecast period. The IVD quality control market is mainly driven by the increasing demand for laboratory accreditations and accredited laboratories. Other key factors include the focus on external quality assessment and the rising adoption of third-party quality controls. The increasing demand for multi-analyte controls is expected to offer potential growth opportunities to market players. However, the unfavorable reimbursement scenario for IVD tests, additional costs involved in the quality control (QC) process, and budget constraints in hospitals and laboratories are expected to restrain the market growth.
Some of the key players in the market include Bio-Rad Laboratories, Inc. (US), Randox Laboratories Ltd. (UK), Thermo Fisher Scientific, Inc. (US), LGC Limited (UK), and Abbott Laboratories (US). Other prominent payers in the market include Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Fortress Diagnostics (UK), SERO AS (US), Sysmex Corporation (Japan), Ortho-Clinical Diagnostics (US), Helena Laboratories Corporation (US), Quidel Corporation (US), Sun Diagnostics, LLC (US), Seegene Inc. (South Korea), ZeptoMetrix Corporation (US), Qnostics (UK), Bio-Techne Corporation (US), Microbiologics (US), Microbix Biosystems (Canada), Streck, Inc. (US), Alpha-Tec Systems (US), Maine Molecular Quality Controls, Inc. (US), and Grifols, S.A. (Spain). These players aim to secure higher market shares through strategies such as product launches, expansions, agreements, and acquisitions.
To know about the assumptions considered for the study download the pdf brochure
Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. holds the leading position in the IVD quality control market. The company provides innovative quality control products and services. It also offers a range of third-party quality controls, data management solutions, and external quality assurance services for hospital laboratories, reference laboratories, transfusion laboratories, and physician office laboratories. The company is expected to sustain its leading market position in the coming years owing to its strong product portfolio, geographic presence, and brand name in the global market.
Thermo Fisher Scientific, Inc
Thermo Fisher Scientific Inc. is ranked second in the world for IVD quality control. The company is a top supplier of IVD quality control goods and services. Clinical chemistry, molecular control, microbiology, serology, serum toxicity testing, specimen validity testing, and therapeutic medication monitoring are among the wide range of quality controls that the company offers. The company has built a reputation for itself as a market leader in IVD quality control owing to its extensive distribution networks and strong geographic presence. The organization focuses on organic and inorganic growth approaches in order to maintain its top position and further grow its market share.
Related Reports:
IVD Quality Control Market by Source (Plasma, Whole Blood, Urine), Technology (Immunoassay, Hematology, Microbiology, Coagulation), Manufacturer (Third party, OEM), End Users (Hospitals, Lab, Research) - Global Forecast to 2027
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
